Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

312 ARTÍCULOS , VIENDO DEL 181 AL 195

Assessing reliable change using the repeatable battery for the assessment of neuropsychological status (RBANS) for patients with Parkinson's Disease undergoing deep brain stimulation (DBS) surgery

Schoenberg MR, Rinehardt E, Duff K, Mattingly M, Bharucha KJ, Scott JG.

Clin Neuropsychol. 2012;26(2):255-70. doi: 10.1080/13854046.2011.653587. Epub 2012 Feb 14.

The use of macroelectrodes in recording cellular spiking activity

Winestone JS, Zaidel A, Bergman H, Israel Z.

J Neurosci Methods. 2012 Apr 30;206(1):34-9. doi: 10.1016/j.jneumeth.2012.02.002. Epub 2012 Feb 11.

Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease

Busse K, Heilmann R, Kleinschmidt S, Abu-Mugheisib M, Höppner J, Wunderlich C, Gemende I, Kaulitz L, Wolters A, Benecke R, Walter U.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):441-7. doi: 10.1136/jnnp-2011-301719. Epub 2012 Feb 22.

The significance of neuronal lateralisation in Parkinson's disease

Riederer P, Sian-Hülsmann J.

J Neural Transm (Vienna). 2012 Aug;119(8):953-62. doi: 10.1007/s00702-012-0775-1. Epub 2012 Feb 26.

Correlation between decreased motor activity and dopaminergic degeneration in the ventrolateral putamen in monkeys receiving repeated MPTP administrations: a positron emission tomography study

Nagai Y, Minamimoto T, Ando K, Obayashi S, Ito H, Ito N, Suhara T.

Neurosci Res. 2012 May;73(1):61-7. doi: 10.1016/j.neures.2012.02.007. Epub 2012 Feb 25.

Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits?

Helmich RC, Hallett M, Deuschl G, Toni I, Bloem BR.

Brain. 2012 Nov;135(Pt 11):3206-26. doi: 10.1093/brain/aws023. Epub 2012 Mar 1.

Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes

Laučkaitė K, Rastenytė D, Šurkienė D, Vaitkus A, Sakalauskas A, Lukoševičius A, Gleiznienė R.

BMC Neurol. 2012 Mar 8;12:12. doi: 10.1186/1471-2377-12-12.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.

Restless legs syndrome responsive to rasagiline treatment: a case report

Babacan-Yildiz G, Gursoy E, Kolukisa M, Celebi A.

Clin Neuropharmacol. 2012 Mar-Apr;35(2):88-9. doi: 10.1097/WNF.0b013e31824c1c3f.

Non-motor symptoms of Parkinson's disease in China: a review of the literature

Chen W, Xu ZM, Wang G, Chen SD.

Parkinsonism Relat Disord. 2012 Jun;18(5):446-52. doi: 10.1016/j.parkreldis.2012.02.002. Epub 2012 Mar 17.

Motor signs in the prodromal phase of Parkinson's disease

Maetzler W, Hausdorff JM.

Mov Disord. 2012 Apr 15;27(5):627-33. doi: 10.1002/mds.24973. Epub 2012 Mar 21.

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS

Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ.

Genes Brain Behav. 2012 Jul;11(5):577-85. doi: 10.1111/j.1601-183X.2012.00779.x. Epub 2012 Apr 6.

Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studies

Lima MM, Martins EF, Delattre AM, Proenca MB, Mori MA, Carabelli B, Ferraz AC.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):439-49. doi: 10.2174/187152712800792893.

Lewy pathology and neurodegeneration in premotor Parkinson's disease

Del Tredici K, Braak H.

Mov Disord. 2012 Apr 15;27(5):597-607. doi: 10.1002/mds.24921.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias